Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ENDRA Life Sciences Inc. Director's Dealing 2024

Aug 15, 2024

35444_dirs_2024-08-15_278faf8a-5fb8-42f0-b420-2128890f6dab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2024-08-08

Reporting Person: Jacroux Richard (N/A)

More from ENDRA Life Sciences Inc.

Regulatory Filings 2026
May 28
Regulatory Filings 2026
May 15
Interim / Quarterly Report 2026
May 15
Regulatory Filings 2026
Apr 21
Annual Report 2026
Mar 31
Regulatory Filings 2026
Mar 31
Regulatory Filings 2026
Mar 25
Director's Dealing 2026
Jan 23
Director's Dealing 2026
Jan 23
Director's Dealing 2026
Jan 23
View all filings →